主页
产品
MyotonPRO
Medestec(美蝶诗)
关于我们
公司新闻
联系我们
/UploadFile/CoolSite/2018-9/201892010949804.png
MyotonPRO数字触诊仪
Myoton技术背景及工作原理
Myoton应用领域
用户表扬信
已发表的论文
常见疑问解答
Myoton重要客户
Combined Treatment Fkt-Botulinum Toxin Type A (Btx-A) in Patients with Strumpell-Lorrain Disease
上一篇:
Myofascial Triggerpoint Release (MTR) for Treating Chronic Shoulder Pain: A New Approach
下一篇:
Reduced Neck Muscle Strength and Altered Muscle Mechanical Properties in Cervical Dystonia Following Botulinum Neurotoxin Injections: A Prospective Study